Department of Radiation Oncology & Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Expert Rev Pharmacoecon Outcomes Res. 2010 Oct;10(5):567-82. doi: 10.1586/erp.10.51.
The field of radiation therapy has made dramatic technical advances over the past 20 years. 3D conformal radiotherapy, intensity-modulated radiation therapy and proton beam therapy have all been developed in an attempt to improve the therapeutic ratio: higher cure rates with lower toxicity. Unfortunately, although the costs of radiation therapy are certainly increasing, it is unclear whether its clinical benefit has also improved. Cost-effectiveness analyses are designed to formally evaluate the cost of a treatment relative to an associated change in quality-adjusted survival. As the cost of oncologic care is increasing, it is critically important to assess the cost-effectiveness of radiation therapy. This article will describe the issues surrounding the delivery and cost of radiation therapy, and it will summarize the work that has been done to evaluate the use of cost-effectiveness in radiation oncology.
在过去的 20 年中,放射治疗领域取得了显著的技术进步。为了提高治疗效果比(即更高的治愈率和更低的毒性),已经开发出了三维适形放疗、调强放疗和质子束治疗等技术。不幸的是,尽管放射治疗的成本肯定在增加,但尚不清楚其临床效益是否也有所提高。成本效益分析旨在正式评估治疗的成本与质量调整生存相关变化的关系。由于肿瘤治疗的成本不断增加,评估放射治疗的成本效益至关重要。本文将描述放射治疗的提供和成本问题,并总结评估放射肿瘤学中成本效益的应用所做的工作。